eli lilly wegovy - Search News

News

Eli Lilly Stock Falls

Barron's on MSN · 17h

Eli Lilly’s Stock Selloff Is Overdone, Analysts Say. Here’s Why.

Analysts were rushing to reiterate their conviction in the stock following Thursday’s blow to Zepbound and Lilly shares.

Bloomberg · 11h

Stock Movers: Apple, Eli Lilly, Spotify

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Newsable Asianet News on MSN · 1d

Eli Lilly Stock Falls After Zepbound Sales Miss, Full-Year Profit Outlook Cut

The company cut its adjusted earnings per share guidance for the full year to $22.50 to $24.00, down from its previous forecast of $20.78 to $22.28.

CVS Health picks Novo's Wegovy

pharmaphorum · 11h

Lilly hit as PBM drops Zepbound, but retains Wegovy

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo Nordisk's newly forged alliances with three leading telehealth companies to drive self-pay sales of its weight loss drug.

Seeking Alpha on MSN · 1d

CVS Health picks Novo’s Wegovy ahead of Lilly’s Zepbound

Eli Lilly (LLY) stock dips as CVS Health (CVS) limits access to its weight loss drug Zepbound in favor of Novo Nordisk's (NVO) Wegovy. Read more here.

Reuters on MSN · 1d

Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell roughly 10% on investor worries that the move could blunt its sales momentum.

17hon MSN

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Fierce Pharma1d

In major blow for Lilly, Novo strikes deal giving Wegovy preferred access on CVS Caremark formulary

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

1don MSN

Eli Lilly CEO waives off CVS, Novo Nordisk deal: 'It feels a little like last decade'

Eli Lilly (LLY) has enjoyed a successful run the past several quarters as the company's blockbuster GLP-1 weight-loss drug ...

1don MSN

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

CVS Health said it will significantly expand access to Novo Nordisk's blockbuster weight loss drug Wegovy for patients ...

2d

Wegovy can treat a dangerous liver disease, study finds

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

3d

Novo Nordisk teams with telehealth firms Hims, Ro to sell Wegovy at lower price

Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...

Scientific American2d

Why Ozempic and Wegovy Might Change Some People’s Favorite Foods

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

3d

Wegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers Comeback

Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results